Diabetes management system developer Diabeloop will use the funding from the Agir à dom and Air Liquide-backed round to accelerate growth.
France-based medical device developer Diabeloop completed a €31m ($34.1m) series B round yesterday featuring home healthcare provider Agir à dom and Aliad, the investment arm of industrial gases supplier Air Liquide.
The €22m equity portion of the round was led by family office Cemag Invest and included financial services firm Crédit Agricole, which participated through its Crédit Agricole Sud Rhône Alpes Capital and Crédit Agricole des Savoie Capital units.
Ceritd, Odyssée Venture, Adag, Sofimac Innovation, Kreaxi and unnamed members of…
Thierry Heles
Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
